Literature DB >> 29549584

Acetylshikonin from Zicao ameliorates renal dysfunction and fibrosis in diabetic mice by inhibiting TGF-β1/Smad pathway.

Zezhao Li1, Zhen Hong2, Zhiqing Peng3, Yongcai Zhao4, Rusheng Shao2.   

Abstract

Diabetic nephropathy (DN) is the major cause of end-stage renal disease in diabetic patients. Zicao, a well-known Chinese traditional medicine, has attracted much attention due to its beneficial effects in various medical fields. In this study, we attempted to investigate the effects and mechanisms of action of acetylshikonin, the main ingredient of Zicao, on renal dysfunction in DN. Our results showed that administration with acetylshikonin not only decreased blood urea nitrogen, urine creatinine and the mean kidney-to-body weight ratio in streptozotocin-induced diabetic mice, but also restored the loss of body weight, whereas the blood glucose was not changed. Masson's trichrome staining showed that acetylshikonin treatment resulted in a marked decrease in kidney fibrosis from diabetic mice. The increased expression of fibrosis proteins, such as plasminogen activator inhibitor type 1 (PAI-1), connective tissue growth factor, and collagen III and IV, were reduced after acetylshikonin administration. In addition, the expressions of interleukin-1β, interleukin-6, monocyte chemoattractant protein-1, intercellular adhesion molecule 1 and infiltration of macrophages in kidney tissues were decreased in acetylshikonin-treated diabetic mice. Acetylshikonin led to a reduction of transforming growth factor-β1 (TGF-β1) expression and Smad-2/3 phosphorylation, as accompanied by increased Smad7 expression. Furthermore, in vitro treatment with acetylshikonin markedly attenuated TGF-β1-induced the PAI-1, collagen III and IV, and Smad-2/3 phosphorylation in HK2 immortalized human proximal tubule epithelial cells. Acetylshikonin also prevented epithelial-to-mesenchymal transition induced by TGF-β1. Collectively, our study provides evidences that acetylshikonin attenuates renal fibrosis though inhibiting TGF-β1/Smad signaling pathway, suggesting that acetylshikonin may be a novel therapeutic agent for the treatment of DN.

Entities:  

Keywords:  Acetylshikonin; Diabetic nephropathy; Inflammation; Renal fibrosis; TGF-β1/Smad

Mesh:

Substances:

Year:  2018        PMID: 29549584     DOI: 10.1007/s13577-017-0192-8

Source DB:  PubMed          Journal:  Hum Cell        ISSN: 0914-7470            Impact factor:   4.174


  35 in total

Review 1.  Transforming growth factor-β/Smad signalling in diabetic nephropathy.

Authors:  Hui Yao Lan
Journal:  Clin Exp Pharmacol Physiol       Date:  2012-08       Impact factor: 2.557

2.  Risk for ESRD in type 1 diabetes remains high despite renoprotection.

Authors:  Elizabeth T Rosolowsky; Jan Skupien; Adam M Smiles; Monika Niewczas; Bijan Roshan; Robert Stanton; John H Eckfeldt; James H Warram; Andrzej S Krolewski
Journal:  J Am Soc Nephrol       Date:  2011-02-25       Impact factor: 10.121

3.  Impaired Mechanics of Left Ventriculo-Atrial Coupling in Patients With Diabetic Nephropathy.

Authors:  Yasuhide Mochizuki; Hidekazu Tanaka; Kensuke Matsumoto; Hiroyuki Sano; Hiroyuki Shimoura; Junichi Ooka; Takuma Sawa; Keiko Ryo-Koriyama; Yushi Hirota; Wataru Ogawa; Ken-Ichi Hirata
Journal:  Circ J       Date:  2016-07-06       Impact factor: 2.993

4.  CTGF mediates TGF-beta-induced fibronectin matrix deposition by upregulating active alpha5beta1 integrin in human mesangial cells.

Authors:  Benjamin S Weston; Nadia Abdel Wahab; Roger M Mason
Journal:  J Am Soc Nephrol       Date:  2003-03       Impact factor: 10.121

Review 5.  TGF-beta and fibrosis in different organs - molecular pathway imprints.

Authors:  Dirk Pohlers; Julia Brenmoehl; Ivonne Löffler; Cornelia K Müller; Carola Leipner; Stefan Schultze-Mosgau; Andreas Stallmach; Raimund W Kinne; Gunter Wolf
Journal:  Biochim Biophys Acta       Date:  2009-06-17

6.  Shikonin derivatives inhibited LPS-induced NOS in RAW 264.7 cells via downregulation of MAPK/NF-kappaB signaling.

Authors:  Yu Wen Cheng; Ching Yi Chang; Kou Lung Lin; Chien Ming Hu; Cheng Hui Lin; Jaw Jou Kang
Journal:  J Ethnopharmacol       Date:  2008-09-12       Impact factor: 4.360

Review 7.  Growth factors and the development of diabetic nephropathy.

Authors:  Gunter Wolf
Journal:  Curr Diab Rep       Date:  2003-12       Impact factor: 5.430

8.  Icariside II ameliorates diabetic nephropathy in streptozotocin-induced diabetic rats.

Authors:  Wenjie Tian; Hongen Lei; Ruili Guan; Yongde Xu; Huixi Li; Lin Wang; Bicheng Yang; Zhezhu Gao; Zhongcheng Xin
Journal:  Drug Des Devel Ther       Date:  2015-09-07       Impact factor: 4.162

9.  Role of endothelial-to-mesenchymal transition induced by TGF-β1 in transplant kidney interstitial fibrosis.

Authors:  Zijie Wang; Zhijian Han; Jun Tao; Jun Wang; Xuzhong Liu; Wanli Zhou; Zhen Xu; Chunchun Zhao; Zengjun Wang; Ruoyun Tan; Min Gu
Journal:  J Cell Mol Med       Date:  2017-04-04       Impact factor: 5.310

10.  Renoprotective effect of berberine via regulating the PGE2 -EP1-Gαq-Ca(2+) signalling pathway in glomerular mesangial cells of diabetic rats.

Authors:  Wei-Jian Ni; Li-Qin Tang; Hong Zhou; Hai-Hua Ding; Yuan-Ye Qiu
Journal:  J Cell Mol Med       Date:  2016-04-21       Impact factor: 5.310

View more
  4 in total

Review 1.  Research Progress of Chinese Herbal Medicine Intervention in Renal Interstitial Fibrosis.

Authors:  Xiao-Yuan Liu; Xu-Bin Zhang; Ya-Feng Zhao; Kai Qu; Xiao-Yong Yu
Journal:  Front Pharmacol       Date:  2022-06-13       Impact factor: 5.988

Review 2.  The Efficacy and Mechanism of Chinese Herbal Medicine on Diabetic Kidney Disease.

Authors:  Zhenzhen Lu; Yifei Zhong; Wangyi Liu; Ling Xiang; Yueyi Deng
Journal:  J Diabetes Res       Date:  2019-08-25       Impact factor: 4.011

3.  Acetylshikonin, A Novel CYP2J2 Inhibitor, Induces Apoptosis in RCC Cells via FOXO3 Activation and ROS Elevation.

Authors:  Heui Min Lim; Jongsung Lee; Seon Hak Yu; Myeong Jin Nam; Hyo Sun Cha; Kyungmoon Park; Yung-Hun Yang; Kyu Yun Jang; See-Hyoung Park
Journal:  Oxid Med Cell Longev       Date:  2022-03-09       Impact factor: 6.543

Review 4.  Pharmacology, toxicity and pharmacokinetics of acetylshikonin: a review.

Authors:  Zhiqin Zhang; Jie Bai; Yawen Zeng; Mengru Cai; Yu Yao; Huimin Wu; Longtai You; Xiaoxv Dong; Jian Ni
Journal:  Pharm Biol       Date:  2020-12       Impact factor: 3.889

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.